Multicenter Neonatal Eye Disease Screening in China

Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT02851251
Collaborator
(none)
30,000
1
29
1034.1

Study Details

Study Description

Brief Summary

These exams are vital to protect healthy neonates from blindness. The purpose of this study is to better screen ocular disease in otherwise healthy neonates using wide-field digital imaging system (RetCam III) in a multi-center network in China leaded by Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. The multi-center network will be built with the collaboration of eight hospitals from different parts of China.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Studies reveal that ocular anomalies may also be found in healthy full-term babies. These abnormal ocular findings included subconjunctival haemorrhage, congenital microphthalmos, congenital corneal leukoma, posterior synechia, persistent pupillary membrane, congenital cataract, enlarged C/D ratio, retinal hamartoma versus retinoblastoma, optic nerve defects, macular pigment disorder and non-specific peripheral retinopathy. The highest proportion of these abnormal findings is retinal haemorrhages, accounting for 92% of abnormalities. Most retinal hemorrhages are benign and will finally self-resolve. However, sometimes it takes a long time for the hemorrhage to resolve. Some slow-resolving hemorrhages could obstruct the visual axis and may do great harm to visual development in critical period. Some neonatal eye diseases are time sensitive, such as retinoblastoma, and if found late, the best opportunity for effective treatment is missed, leading to irreversible visual impairment. Newborns are unable to express their discomforts or visual disorders as adults do and only through an examination, the neonatal eye diseases can be detected. Therefore, this screening protocol is designed to screen the otherwise healthy neonates in a multi-center network on neonatal ophthalmopathy and to achieve early diagnosis and timely treatment. All the neonates will undergo eye examination by using RetCam III. The external eye, pupillary light reflex, red reflex, opacity of refractive media, anterior chamber and posterior segments will be examined. The outcomes will be analyzed by a blinded specialist in order to discover serious congenital, hereditary and acquired diseases in the neonatal period of healthy newborns and to improve epidemiological information of neonatal ophthalmopathy. Neonatal ocular examination may play a positive role in promoting paediatric eye health to paediatricians and parents.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    30000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Multicenter Neonatal Eye Disease Screening in China
    Study Start Date :
    Jul 1, 2016
    Actual Primary Completion Date :
    Dec 1, 2018
    Actual Study Completion Date :
    Dec 1, 2018

    Outcome Measures

    Primary Outcome Measures

    1. presence of ocular disease [2 to 7 days after birth]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Days to 7 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Otherwise healthy neonates ( ≥37weeks' gestational age, weighing ≥2500 g, no evidence of systemic disease and an Apgar score of 7 or more.)
    Exclusion Criteria:
    • Preterm /Neonates with systemic diseases

    • Neonates unable to undergo the examination

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China 200092

    Sponsors and Collaborators

    • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    Investigators

    • Principal Investigator: Peiquan Zhao, MD, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, China

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Peiquan Zhao, Professor, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
    ClinicalTrials.gov Identifier:
    NCT02851251
    Other Study ID Numbers:
    • XH-16-019
    First Posted:
    Aug 1, 2016
    Last Update Posted:
    Sep 23, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Peiquan Zhao, Professor, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 23, 2021